Search for a doctor

Erin E. Wiedmeier-Nutor, M.D., M.P.H.

  1. Hematologist

Publications

  1. Wiedmeier-Nutor JE, McCabe CE, O'Brien DR, Jessen E, Bonolo de Campos C, Boddicker NJ, Griffin R, Allmer C, Rabe KG, Cerhan JR, Parikh SA, Kay NE, Yan H, Van Dyke DL, Slager SL, Braggio E. Utility of Targeted Sequencing Compared to FISH for Detection of Chronic Lymphocytic Leukemia Copy Number Alterations. Cancers (Basel). 2024 Jul 3; 16 (13) Epub 2024 July 03
    View PubMed
  2. Wiedmeier-Nutor JE, Golafshar MA, Kunze KL, Esplin ED, Nussbaum RL, Heald B, Stewart AK, Samadder NJ, Bergsagel PL, Fonseca R. Pathogenic germline variants in a prospective multi-center cohort of patients with multiple myeloma. Blood Neoplasia. 2024; Accepted for Publication.
  3. Griffin R, Wiedmeier-Nutor JE, Parikh SA, McCabe CE, O'Brien DR, Boddicker NJ, Kleinstern G, Rabe KG, Bruins L, Brown S, Bonolo de Campos C, Ding W, Leis JF, Hampel PJ, Call TG, Van Dyke DL, Kay NE, Cerhan JR, Yan H, Slager SL, Braggio E. Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLL. Blood Adv. 2023 Jul 11; 7 (13):3169-3179
    View PubMed
  4. Wiedmeier-Nutor JE, Iqbal M, Rosenthal AC, Bezerra ED, Garcia-Robledo JE, Bansal R, Johnston PB, Hathcock M, Larsen JT, Bergsagel PL, Wang Y, Reeder CB, Leis JF, Fonseca R, Palmer JM, Gysbers BJ, Mwangi R, Warsame RM, Kourelis T, Hayman SR, Dingli D, Kapoor P, Kumar SK, Durani U, Villasboas JC, Paludo J, Bennani NN, Nowakowski G, Ansell SM, Castro JE, Kharfan-Dabaja MA, Lin Y, Vergidis P, Murthy HS, Munoz J. Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2023 Jun; 23 (6):456-462 Epub 2023 Mar 07
    View PubMed
  5. Fonseca R, Arribas M, Wiedmeier-Nutor JE, Kusne YN, Gonzalez Velez M, Kosiorek HE, Butterfield RDJ, Kirsch IR, Mikhael JR, Stewart AK, Reeder C, Larsen J, Bergsagel PL, Fonseca R. Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood Cancer J. 2023 May 26; 13 (1):87
    View PubMed
  6. Fonseca R, Arribas M, Wiedmeier-Nutor JE, Kusne YN, Gonzalez Velez M, Kosiorek HE, Butterfield RDJ, Kirsch IR, Mikhael JR, Stewart AK, Reeder C, Larsen J, Bergsagel PL, Fonseca R. Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood Cancer J. 2023 Mar 6; 13 (1):32 Epub 2023 Mar 06
    View PubMed
  7. Bering JL, Wiedmeier-Nutor JE, Sproat L, DiBaise JK. Bone marrow oxalosis with pancytopenia in a patient with short bowel syndrome: Report of a case and review of the literature. JPEN J Parenter Enteral Nutr 2023 Jan; 47 (1):165-170 Epub 2022 Oct 17
    View PubMed
  8. Wiedmeier-Nutor J, Leis J. Chronic Lymphocytic Leukemia: Chemotherapy Free and Other Novel Therapies Including CAR T. Curr Treat Options Oncol. 2022 Jun; 23 (6):904-919 Epub 2022 Apr 18
    View PubMed
  9. Wiedmeier-Nutor JE, Bergsagel PL. Review of Multiple Myeloma Genetics including Effects on Prognosis, Response to Treatment, and Diagnostic Workup. Life (Basel). 2022 May 30; 12 (6)
    View PubMed
  10. Fortin Ensign SP, Gathers D, Wiedmeier JE, Mrugala MM. Central Nervous System Lymphoma: Novel Therapies. Curr Treat Options Oncol. 2022 Jan; 23 (1):117-136 Epub 2022 Feb 19
    View PubMed
  11. Xie Z, Saliba AN, Abeykoon J, Majeed U, Almquist DR, Wiedmeier-Nutor JE, Bezerra E, Andrade-Gonzalez X, Hickman A, Sorenson K, Rakshit S, Wee C, Tella SH, Kommalapati A, Abdallah N, Pritchett J, De Andrade M, Uprety D, Badley A, Manochakian R, Ailawadhi S, Bryce AH, Hubbard JM, Gangat N, Thompson CA, Witzig TE, McWilliams RR, Leventakos K, Halfdanarson TR. Outcomes of COVID-19 in Patients With Cancer: A Closer Look at Pre-Emptive Routine Screening Strategies. JCO Oncol Pract. 2021 Sep; 17 (9):e1382-e1393 Epub 2021 June 14
    View PubMed
  12. Aslam F, Wiedmeier JE, DiCaudo DJ. A Man With Recurrent Fever, Episodic Rash, and Pain. Arthritis Care Res (Hoboken). 2021 Aug; 73 (8):1106-1113 Epub 2021 July 14
    View PubMed
  13. Wiedmeier JE, Mountjoy LJ, Buras MR, Kosiorek HE, Coppola KE, Verona PM, Cook CB, Karlin NJ. Mortality and glycemic control among patients with acute and chronic myeloid leukemia and diabetes: a case-control study. Future Sci OA. 2020 Oct 26; 7 (1):FSO639
    View PubMed
  14. Wiedmeier JE, Noel P, Lin W, Von Hoff DD, Han H. Single-Cell Sequencing in Precision Medicine. Cancer Treat Res. 2019; 178:237-252
    View PubMed
  15. Wiedmeier JE, Ohlrich A, Chu A, Rountree MR, Turker MS. Induction of the long noncoding RNA NBR2 from the bidirectional BRCA1 promoter under hypoxic conditions. Mutat Res. 2017 Feb; 796:13-19 Epub 2017 Feb 16
    View PubMed
  16. Wiedmeier JE, Kato C, Zhang Z, Lee H, Dunlap J, Nutt E, Rattray R, McKay S, Eide C, Press R, Mori M, Druker B, Dao KH. Clonal hematopoiesis as determined by the HUMARA assay is a marker for acquired mutations in epigenetic regulators in older women. Exp Hematol. 2016 Sep; 44 (9):857-865.e5 Epub 2016 May 26
    View PubMed
  17. McKnight RA, Yost CC, Yu X, Wiedmeier JE, Callaway CW, Brown AS, Lane RH, Fung CM. Intrauterine growth restriction perturbs nucleosome depletion at a growth hormone-responsive element in the mouse IGF-1 gene. Physiol Genomics. 2015 Dec; 47 (12):634-43 Epub 2015 Oct 20
    View PubMed
  18. Wiedmeier JE, Joss-Moore LA, Lane RH, Neu J. Early postnatal nutrition and programming of the preterm neonate. Nutr Rev. 2011 Feb; 69 (2):76-82
    View PubMed
PST-20552936